70 related articles for article (PubMed ID: 8222432)
1. Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption.
Oreffo RO; Marshall GJ; Kirchen M; Garcia C; Gallwitz WE; Chavez J; Mundy GR; Bonewald LF
Clin Orthop Relat Res; 1993 Nov; (296):229-41. PubMed ID: 8222432
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
3. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
[TBL] [Abstract][Full Text] [Related]
4. Cellular and hormonal mechanisms associated with malignant bone resorption.
Quinn JM; Matsumura Y; Tarin D; McGee JO; Athanasou NA
Lab Invest; 1994 Oct; 71(4):465-71. PubMed ID: 7526033
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells.
Ito M; Amizuka N; Tanaka S; Funatsu-Ozawa Y; Kenmotsu S; Oda K; Nakajima T; Ozawa H
J Bone Miner Metab; 2003; 21(6):353-62. PubMed ID: 14586791
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
McSheehy PM; Chambers TJ
J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
[TBL] [Abstract][Full Text] [Related]
7. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
[TBL] [Abstract][Full Text] [Related]
8. Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.
Gouin F; Couillaud S; Cottrel M; Godard A; Passuti N; Heymann D
Cytokine; 1999 Apr; 11(4):282-9. PubMed ID: 10328867
[TBL] [Abstract][Full Text] [Related]
9. The expression of mRNA for insulin-like growth factors and their receptor in giant cell tumors of human bone.
Middleton J; Arnott N; Walsh S; Beresford J
Clin Orthop Relat Res; 1996 Jan; (322):224-31. PubMed ID: 8542699
[TBL] [Abstract][Full Text] [Related]
10. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
11. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
12. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast.
Komiya S; Sasaguri Y; Inoue A; Nakashima M; Yamamoto S; Yanagida I; Morimatsu M
Clin Orthop Relat Res; 1990 Sep; (258):304-9. PubMed ID: 2168302
[TBL] [Abstract][Full Text] [Related]
14. New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone.
Grano M; Colucci S; De Bellis M; Zigrino P; Argentino L; Zambonin G; Serra M; Scotlandi K; Teti A; Zambonin Zallone A
J Bone Miner Res; 1994 Jul; 9(7):1013-20. PubMed ID: 7942147
[TBL] [Abstract][Full Text] [Related]
15. Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells.
Miyamoto N; Higuchi Y; Tajima M; Ito M; Tsurudome M; Nishio M; Kawano M; Sudo A; Uchida A; Ito Y
J Orthop Res; 2000 Jul; 18(4):647-54. PubMed ID: 11052502
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytokines on in vitro bone resorption by cells isolated from giant cell tumor of bone.
Wen J; Xie D; Yao J; Zhang M; Bi J
Chin Med J (Engl); 1999 May; 112(5):443-7. PubMed ID: 11593516
[TBL] [Abstract][Full Text] [Related]
17. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
[TBL] [Abstract][Full Text] [Related]
18. Functional and biochemical characterization of osteoclast-like cells derived from giant cell tumours of bone.
Grano M; Colucci S; Portoghese A; Zambonin G; Barattolo R; Serra M; Scotlandi K; Teti A; Zambonin Zallone A
Boll Soc Ital Biol Sper; 1992 Apr; 68(4):249-53. PubMed ID: 1463598
[TBL] [Abstract][Full Text] [Related]
19. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
